Search Results 11-20 of 16217 for what is vedolizumab

1. Crohn's Disease Clinical Trials - Mayo Clinic Research

   The purpose of this study is to assess the effect of vedolizumab subcutaneous (vedolizumab SC) as maintenance treatment in participants with moderately to ...

2. Vedolizumab IV 300 mg in the Treatment of Fistulizing Crohn's Disease - Mayo Clinic

   The purpose of this study is to evaluate perianal fistula healing at Week 30 in 2 different dose regimens of vedolizumab intravenous (IV) 300 milligram (mg) in ...

3. Vedolizumab (Intravenous Route, Subcutaneous Route) Before Using - Mayo Clinic

   Pediatric. Appropriate studies have not been performed on the relationship of age to the effects of vedolizumab injection in the pediatric population. Safety ...

4. Vedolizumab IV in Pediatric Participants With Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   The purpose of this study is to evaluate vedolizumab pharmacokinetics (PK), safety and tolerability in pediatric participants with moderately to severely active ...

5. A Study Comparing the Long Term Safety of Entyvio (Vedolizumab) to Other Biologic Agents in Patients with Ulcerative Colitis or Crohn's Disease - Mayo Clinic

   The purpose of this study is to assess the long-term safety of vedolizumab versus other biologic agents in participants with Ulcerative Colitis or Crohn's ...

6. Long-term Safety With Vedolizumab Intravenous (IV) in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   ... Ulcerative Colitis (UC) or Crohn's Disease (CD) ... The purpose of this study is to determine the safety profile of long-term vedolizumab IV treatment in ...

7. Vedolizumab Subcutaneous Long-Term Open-Label Extension Study - Mayo Clinic

   ... vedolizumab subcutaneous (vedolizumab SC) in participants with ulcerative colitis (UC) and Crohn's disease (CD). Participation eligibility. Participant ...

8. Infliximab-Dyyb (Intravenous Route, Subcutaneous Route) Description and Brand Names - Mayo Clinic

   It is also used as a maintenance treatment for moderate to severe active Crohn's disease and ulcerative colitis after receiving an infliximab medicine given by ...

9. A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   The purpose of this study is to determine the long-term safety of vedolizumab intravenous (IV) treatment in pediatric participants with Ulcerative Colitis (UC) ...

10. Efficacy and Safety of Vedolizumab Subcutaneous (SC) as Maintenance Therapy in Crohn's Disease - Mayo Clinic

    ... Crohn's disease (CD) who achieved clinical response following administration of vedolizumab intravenous (vedolizumab IV) induction therapy. Participation ...